Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 2
2014 2
2015 1
2016 3
2017 3
2018 1
2020 1
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
New Assessment Tool-Postpartum Functional Assessment Questionnaire.
Filipec M, Blagaić V, Jadanec Đurin M, Zekan P, Hrabač P, Zovko A. Filipec M, et al. Among authors: zovko a. Medicina (Kaunas). 2023 Jun 29;59(7):1219. doi: 10.3390/medicina59071219. Medicina (Kaunas). 2023. PMID: 37512032 Free PMC article.
Redistribution of gangliosides accompanies thermally induced Na+, K+-ATPase activity alternation and submembrane localisation in mouse brain.
Puljko B, Stojanović M, Ilic K, Maček Hrvat N, Zovko A, Damjanović V, Mlinac-Jerkovic K, Kalanj-Bognar S. Puljko B, et al. Among authors: zovko a. Biochim Biophys Acta Biomembr. 2021 Jan 1;1863(1):183475. doi: 10.1016/j.bbamem.2020.183475. Epub 2020 Sep 18. Biochim Biophys Acta Biomembr. 2021. PMID: 32956659 Free article. No abstract available.
IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors.
Ujvari D, Malyukova A, Zovko A, Yektaei-Karin E, Madapura HS, Keszei M, Nagy N, Lotfi K, Björn N, Wallvik J, Stenke L, Salamon D. Ujvari D, et al. Among authors: zovko a. Oncoimmunology. 2022 Aug 12;11(1):2109861. doi: 10.1080/2162402X.2022.2109861. eCollection 2022. Oncoimmunology. 2022. PMID: 35979386 Free PMC article.
Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells.
Malyukova A, Ujvari D, Yektaei-Karin E, Zovko A, Madapura HS, Keszei M, Nagy N, Lotfi K, Björn N, Wallvik J, Tamai M, Nguyen TTT, Akahane K, Inukai T, Stenke L, Salamon D. Malyukova A, et al. Among authors: zovko a. Cell Death Dis. 2021 Sep 25;12(10):875. doi: 10.1038/s41419-021-04154-0. Cell Death Dis. 2021. PMID: 34564697 Free PMC article.
17 results